Augmented production of Panton-Valentine leukocidin toxin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus is associated with worse outcome in a murine skin infection model.

The Journal of Infectious Diseases
Avanish K VarshneyBettina C Fries

Abstract

The role of Panton-Valentine leukocidin (PVL) in Staphylococcus aureus infections is controversial. We used a mouse model of skin infection to compare the virulence of methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) strains with different levels of PVL production. Differences in PVL production were not associated with mutations in the genes lukS-PV and lukF-PV. However, MSSA and MRSA strains that produced high levels of PVL caused larger skin abscesses, higher bacterial burdens, and more tissue inflammation than did low-PVL-producing strains. Together, these data suggest that (1) the effect of PVL on the pathogenesis of staphylococcal infection may depend on the level of toxin produced and (2) many strains of MSSA that cause soft-tissue infections produce higher levels of PVL than do MRSA strains.

Citations

Jun 4, 2013·Archives of Disease in Childhood·Marta Barrios LópezPablo Rojo
May 12, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yaw-Kwan ChiuChih-Chien Wang
Oct 16, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Thomas TsaganosEvangelos J Giamarellos-Bourboulis
Jan 25, 2011·Molecular Microbiology·Ashley L DumontVictor J Torres
Jul 19, 2012·The British Journal of Dermatology·M DemosK Nouri
Jan 8, 2014·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Stefanie WaldenburgerAnnette Kolb-Mäurer
Jun 30, 2012·Journal of Medical Microbiology·Richard R WatkinsRobert A Salata
May 17, 2014·Scandinavian Journal of Infectious Diseases·Eunice Mireya Borbón-EsquerMariana Del Rocío Ruiz-Briseño
Jul 18, 2014·Expert Review of Respiratory Medicine·Christian Woods, Gene Colice
Aug 9, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Monica CorazzaCarlo Contini

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.